"Integration, integration, integration"!
Dame Janet Thornton describes how she came up with the idea for the Open Targets Platform
The full Open Targets founders panel is available to watch on YouTube: https://t.co/Fsk7k9lerA
#OpenTargetsAt10
Transcription is the process by which the information in DNA is copied into messenger nRNA (mRNA) for protein production.
This is a visualization of how it takes place.
[🎞️ dnalearningcenter]
Happy one-year anniversary to Open Targets’ Executive Director @DavidHulcoop! 🥳
David shares three reflections from his first year leading the consortium on the Open Targets blog.
https://t.co/SgNAhWwjAa
On this day, 50 years ago, EMBL was established!
Today, we celebrate five decades of EMBL, fuelled by infinite curiosity. EMBL turns 50, and we’d like to extend a huge thank you to everyone who contributed to reaching this milestone!
#EMBL50
Happy to see #quantms out https://t.co/j26W0VvpUD. Thanks to the main authors Dai & Julianus. The @OpenMSTeam@OKohlbacher & @DemichevLab for the support with OpenMS and DIANN. Thanks to @lukas_k for his incredible work with the data. Thanks to @nf_core & @nextflowio platforms.
Deploy your own Open Targets Platform in your environment of choice! The latest new contribution to life sciences by the Open Targets Team, that will open the doors to improved reproducibility, collaborations, prototyping, outreach and training activities
🏗️ Want to tinker with the Open Targets Platform to add your own data or tools? Need to check past versions of the Platform?
Introducing the Standalone Deployment tool, which allows you to easily deploy any Platform release since March 2023 on your local machine
🏗️ Want to tinker with the Open Targets Platform to add your own data or tools? Need to check past versions of the Platform?
Introducing the Standalone Deployment tool, which allows you to easily deploy any Platform release since March 2023 on your local machine
Thank you to everyone who attended and presented at yesterday's Integration Day — a chance to dive deeper into current and potential future work in single cell sequencing 🧪🧬
How and why was Open Targets founded?
Former Director @DunhamReal explains how discussions between Janet Thornton, Mike Stratton, and Patrick Vallance led to the founding of the Open Targets consortium (recorded in 2021)
Last week the core team got together to celebrate 10 years of Open Targets, featuring a ten-themed quiz and some fiendishly good cake 🎂
#OpenTargetsAt10
🚨 It’s the release klaxon! Open Targets Platform 24.03 is out now!
A major highlight: 2.8 million evidence of target-disease association now benefit from a Direction of Effect assessment, describing the relationship between gene and trait
https://t.co/LQfIoFfpCE
I’m humbled to be part of our shared history, each moment we’ve built upon, every challenge we’ve navigated, has been a step in a journey that’s larger than any one of us. Here’s to the stories we’ve written and the chapters yet to come🥂#OpenTargetsAt10
Double digits!
Open Targets was founded 10 years ago today 🎂
Over the next year, we'll be reflecting on key achievements and looking forward to the next decade and beyond... #OpenTargetsAt10
Congratulations to the whole team at Open Targets, past and present!🥂
Happy #InternationalMotherLanguageDay!
Our team celebrated by sharing some of their favourite words and phrases with each other — how many do you know?
🇺🇸🇮🇹🇨🇳🇪🇸🇮🇷🇩🇪🇰🇪🇬🇧🇷🇺🇮🇳🇨🇴🇵🇱🌍
Freshly unveiled in #EMDB & @PDBeurope and now featured in @NatureComms—the first #CryoEM structure at 3.29 Å of Dickeya dianthicola, a notorious plant pathogen linked to soft rot diseases.
How *does* Open Targets facilitate pre-competitive insights for systematic drug target selection? (And can you say that five times fast?)
Come find out! #FoG2024
The Open Targets Platform has had some exciting updates ✨
Join our webinar next week to find out how you can use the Platform to explore target-disease associations and more with our new Associations on the Fly and Target Prioritisation views
See you there!